Medical device company
Appears in 1 story · Last updated Sep 23, 2026
As of September 2026: Developer of SELUTION SLR; technology now owned by Cordis
On September 21, the FDA approved the first sirolimus drug-eluting balloon for coronary use in the US. Cordis' SELUTION SLR expands inside a narrowed artery, releases sirolimus for up to 90 days, then is removed. No permanent implant stays behind.
Updated Sep 23
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?
